AIG
American International Group’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-57,491
| Closed | -$1.78M | – | 303 |
|
|
2024
Q1 | $1.78M | Buy |
57,491
+565
| +1% | +$17.5K | 0.01% | 1055 |
|
|
2023
Q4 | $2.3M | Sell |
56,926
-230
| -0.4% | -$9.29K | 0.01% | 956 |
|
|
2023
Q3 | $1.51M | Sell |
57,156
-920,656
| -94% | -$24.3M | 0.01% | 1047 |
|
|
2023
Q2 | $16.8M | Sell |
977,812
-1,726,562
| -64% | -$29.7M | 0.1% | 164 |
|
|
2023
Q1 | $44.8M | Sell |
2,704,374
-1,015,711
| -27% | -$16.8M | 0.29% | 47 |
|
|
2022
Q4 | $28.3M | Buy |
3,720,085
+419
| +0% | +$3.19K | 0.2% | 85 |
|
|
2022
Q3 | $37M | Buy |
3,719,666
+702
| +0% | +$6.98K | 0.27% | 53 |
|
|
2022
Q2 | $33.8M | Sell |
3,718,964
-3,716
| -0.1% | -$33.7K | 0.23% | 68 |
|
|
2022
Q1 | $37.8M | Sell |
3,722,680
-3,708
| -0.1% | -$37.6K | 0.21% | 76 |
|
|
2021
Q4 | $62.2M | Sell |
3,726,388
-2,516
| -0.1% | -$42K | 0.31% | 47 |
|
|
2021
Q3 | $175M | Sell |
3,728,904
-1,398
| -0% | -$65.5K | 0.93% | 9 |
|
|
2021
Q2 | $227K | Buy |
3,730,302
+5,468
| +0.1% | +$333 | 0.77% | 20 |
|
|
2021
Q1 | $229K | Buy |
3,724,834
+382,500
| +11% | +$23.6K | 0.8% | 21 |
|
|
2020
Q4 | $238K | Sell |
3,342,334
-2,277,594
| -41% | -$162K | 0.88% | 16 |
|
|
2020
Q3 | $183M | Sell |
5,619,928
-991
| -0% | -$32.4K | 0.88% | 27 |
|
|
2020
Q2 | $183M | Sell |
5,620,919
-298,327
| -5% | -$9.73M | 0.88% | 32 |
|
|
2020
Q1 | $172M | Sell |
5,919,246
-825,146
| -12% | -$23.9M | 0.94% | 29 |
|
|
2019
Q4 | $236M | Sell |
6,744,392
-2,119
| -0% | -$74.3K | 0.91% | 34 |
|
|
2019
Q3 | $145M | Buy |
6,746,511
+14,267
| +0.2% | +$306K | 0.58% | 36 |
|
|
2019
Q2 | $182M | Buy |
+6,732,244
| New | +$182M | 0.71% | 34 |
|